Recordati Industria Chimica e Farmaceutica S.p.A. (BIT: REC)

REC Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,067	2,407	1,511	2,479	2,213	1,962
Cash & Short-Term Investments	1,067	2,407	1,511	2,479	2,213	1,962
Cash Growth	-1.84%	59.30%	-39.05%	12.02%	12.79%	-4.48%
Accounts Receivable	7,867	7,321	6,990	6,951	6,092	5,923
Other Receivables	356	287	223	303	330	241
Receivables	8,526	7,813	7,318	7,254	6,589	6,361
Inventory	6,214	5,693	5,338	5,486	5,882	5,823
Prepaid Expenses	155	140	110	104	97	79
Other Current Assets	570	345	362	246	409	332
Total Current Assets	16,532	16,398	14,639	15,569	15,190	14,557
Property, Plant & Equipment	3,257	3,108	2,904	2,652	2,542	2,608
Long-Term Investments	1,786	2,101	2,122	1,345	1,087	1,173
Goodwill	4,485	3,899	3,925	3,836	3,628	3,825
Other Intangible Assets	1,104	742	768	634	596	631
Long-Term Deferred Tax Assets	1,158	1,213	1,133	1,035	1,093	1,096
Long-Term Deferred Charges	2,987	2,953	2,746	2,624	2,438	2,459
Other Long-Term Assets	260	262	332	670	483	526
Total Assets	31,569	30,693	28,582	28,379	27,073	26,893
Accounts Payable	3,299	3,268	3,054	3,372	3,619	3,791
Accrued Expenses	1,105	952	931	870	711	773
Short-Term Debt	-	1	1	1	2	2
Current Portion of Long-Term Debt	1,886	1,965	1,004	1,489	1,773	984
Current Portion of Leases	82	79	78	82	75	64
Current Income Taxes Payable	84	104	127	44	37	43
Current Unearned Revenue	9,236	8,939	8,199	8,076	7,895	7,906
Other Current Liabilities	1,721	1,691	1,784	1,662	1,807	1,778
Total Current Liabilities	17,413	16,999	15,178	15,596	15,919	15,341
Long-Term Debt	1,847	2,354	3,039	3,626	3,400	3,588
Long-Term Leases	559	531	492	486	480	387
Long-Term Unearned Revenue	82	84	79	80	82	87
Long-Term Deferred Tax Liabilities	365	268	246	340	233	245
Other Long-Term Liabilities	1,592	1,595	1,534	1,434	1,281	1,402
Total Liabilities	22,172	22,132	20,883	21,924	21,795	21,559
Common Stock	2,544	2,544	2,544	2,544	2,544	2,544
Retained Earnings	6,030	5,660	4,975	4,185	3,574	3,427
Treasury Stock	-26	-26	-26	-26	-27	-29
Comprensive Income & Other	-242	-378	-310	-275	-824	-619
Total Common Equity	8,306	7,800	7,183	6,428	5,267	5,323
Minority Interest	1,091	761	516	27	11	11
Shareholders' Equity	9,397	8,561	7,699	6,455	5,278	5,334
Total Liabilities & Equity	31,569	30,693	28,582	28,379	27,073	26,893
Total Debt	4,374	4,930	4,614	5,684	5,730	5,025
Net Cash (Debt)	-3,307	-2,523	-3,103	-3,205	-3,517	-3,063
Net Cash Per Share	-5.75	-4.39	-5.39	-5.57	-6.12	-5.33
Filing Date Shares Outstanding	575.31	575.31	575.31	575.31	575.17	575.01
Total Common Shares Outstanding	575.31	575.31	575.31	575.31	575.17	575.01
Working Capital	-881	-601	-539	-27	-729	-784
Book Value Per Share	14.44	13.56	12.49	11.17	9.16	9.26
Tangible Book Value	2,717	3,159	2,490	1,958	1,043	867
Tangible Book Value Per Share	4.72	5.49	4.33	3.40	1.81	1.51
Land	-	1,807	1,689	1,647	1,585	1,518
Machinery	-	4,517	4,314	4,212	4,003	3,930
Construction In Progress	-	399	391	250	216	249
Order Backlog	-	39,529	37,506	35,534	35,516	36,513

Source: S&P Capital IQ. Standard template. Financial Sources.